Life sciences companies need to deliver to market safely and securely through a time sensitive, regulatory-intensive environment and across a process-driven product lifecycle. Further, they are required to guarantee continued safe and efficacious supply of their product as long as it is marketed. The governing regulations also require sponsors to maintain a safety and surveillance program in support of safe and efficacious supply.